関連する実験動画
Updated: Jan 31, 2026

08:30
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
14.9K
用量-曝露-反応の共通の推定値とその因果的識別可能性の条件
Christian Bartels1, Yuchen Wang2, Jonathan French3
1Novartis Pharma AG, Basel, Switzerland.
CPT: pharmacometrics & systems pharmacology
|January 30, 2026
まとめ
用量-曝露-反応(DER)解析への推定値フレームワークの適用は、薬剤開発における用量選択を強化します。因果推論を統合したこの構造化されたアプローチは、DERモデリング結果の精度と解釈可能性を向上させます。
科学分野:
- 薬物動態学
- 薬剤開発
- 因果推論
背景:
- 曝露反応(ER)解析は、薬剤開発における用量選択にとって重要です。
- 推定値フレームワーク(ICH E9(R1))は、正確な科学的目標定義を提供します。
- 標準的なER解析では、因果推論の原則との正式な統合がしばしば欠けています。
主な方法:
- 実際のシナリオに基づいたシミュレーション研究が使用されました。
- 推定値は、潜在的結果表記を使用して定義および形式化されました。
- 有向非巡回グラフ(DAG)は、研究の仮定と関係を表現しました。
- 3つの推定アプローチが導き出されました:プールされたDER、プールされた共変量調整DR、およびコホート要約。
結論:
- 推定値フレームワークと因果推論の統合は、DER解析における方法論的厳密性を向上させます。
- このアプローチは、モデリングの仮定の明確さと結果の解釈を向上させます。
- 一般化可能な戦略は、特に複数の研究データを用いた精密な用量選択のための曝露反応解析を進歩させます。
関連する概念動画
Dose-Response Relationship: Overview
5.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.1K
Causality in Epidemiology
1.6K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.6K
Dose-Response Relationship: Potency and Efficacy
6.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K
Dose-Response Relationship: Selectivity and Specificity
9.7K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.7K
Common Ion Effect
46.6K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
46.6K
Dose Size and Dosing Frequency: Determination Methods
291
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
291

